Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

PDS Biotechnology Corp.

Start price
Target price
Perf. (%)
€1.73
30.06.20
-
24.10.20
3.47%
24.10.20

buy
Chugai Pharmaceutical Co Ltd

Start price
Target price
Perf. (%)
€49.67
26.06.20
-
31.07.20
-21.88%
31.07.20

buy
Sintx Technologies Inc.

Start price
Target price
Perf. (%)
€214.00
20.06.20
-
23.06.20
-43.93%
23.06.20

buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€49.48
19.06.20
€55.00
04.11.21
12.05%
04.04.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€2.30
17.06.20
€5.00
04.11.21
73.91%
12.08.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Higher risks for its business
High valuation
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€22.00
16.06.20
-
02.07.20
35.45%
02.07.20

buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€92.99
15.06.20
€111.00
04.11.21
18.72%
05.11.21

buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€2.48
14.06.20
€5.00
04.11.21
-8.87%
05.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Immuron

Start price
Target price
Perf. (%)
€14.90
09.06.20
-
10.06.20
-45.64%
10.06.20

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.87
08.06.20
€65.00
04.11.21
-18.67%
05.11.21

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Eurobio scientific

Start price
Target price
Perf. (%)
€7.42
06.06.20
€20.00
04.11.21
131.94%
05.11.21

Could be worthwhile Investment >10% per year
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€131.66
06.06.20
€205.00
04.11.21
77.81%
05.11.21

Could be worthwhile Investment >10% per year
buy
Evofem Biosciences Inc.

Start price
Target price
Perf. (%)
€46.05
06.06.20
€45.00
04.11.21
-81.42%
05.11.21

Risky Investment
buy
Lysogene SA

Start price
Target price
Perf. (%)
€2.80
05.06.20
€3.30
04.11.21
-18.39%
24.09.21

Could be worthwhile Investment >10% per year
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€264.80
05.06.20
€290.00
12.10.20
5.70%
12.10.20

buy
Hexo Corp.

Start price
Target price
Perf. (%)
€35.28
02.06.20
€42.00
17.06.20
19.05%
17.06.20

Higher risks for its business
buy
Novacyt S.A.

Start price
Target price
Perf. (%)
€3.70
31.05.20
€5.00
04.11.21
-12.32%
04.10.21

Could be worthwhile Investment >10% per year
buy
Nanobiotix

Start price
Target price
Perf. (%)
€8.08
29.05.20
€11.00
04.11.21
9.22%
05.11.21

Could be worthwhile Investment >10% per year
buy
Qualigen Therapeutics Inc.

Start price
Target price
Perf. (%)
€56.20
28.05.20
-
09.07.20
-35.59%
09.07.20

buy
Evofem Biosciences Inc.

Start price
Target price
Perf. (%)
€102.90
25.05.20
€135.00
04.11.21
-86.11%
17.06.21

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€3.70
24.05.20
€5.00
26.06.20
-0.54%
26.06.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€18.68
21.05.20
€30.00
04.11.21
531.06%
05.11.21

Could be worthwhile Investment >10% per year
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€66.80
20.05.20
€60.00
25.05.20
4.09%
25.05.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.08
20.05.20
€4.50
04.11.21
56.99%
05.11.21

Could be worthwhile Investment >10% per year
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€7.40
16.05.20
€2.00
27.06.20
-30.43%
27.06.20